APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Edoxaban Tosilate Tablets and Generic Drugs

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Edoxaban Tosilate Tablets and Generic Drugs Market Analysis and Forecast 2026-2032

29 December 2025190 pages

Choose your research edition.

Industry ResearchEdoxaban Tosilate Tablets and Generic Drugs Industry Research Report 2026107 pages · $2,950 USDIndustry Growth & TrendsGlobal Edoxaban Tosilate Tablets and Generic Drugs Industry Growth and Trends Forecast to 203278 pages · $3,450 USDMarket StructureGlobal Edoxaban Tosilate Tablets and Generic Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032173 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Edoxaban Tosilate Tablets and Generic Drugs Market Outlook and Growth Opportunities 2026196 pages · $4,250 USDMarket Analysis & ForecastGlobal Edoxaban Tosilate Tablets and Generic Drugs Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

The global Edoxaban Tosilate Tablets and Generic Drugs market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Edoxaban Tosilate Tablets and Generic Drugs is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Edoxaban Tosilate Tablets and Generic Drugs is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Edoxaban Tosilate Tablets and Generic Drugs is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Edoxaban Tosilate Tablets and Generic Drugs is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Edoxaban Tosilate Tablets and Generic Drugs include Daiichi Sankyo, Lunan Pharmaceutical Group, Menarini Group and Simcere Pharmaceutical, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Edoxaban Tosilate Tablets and Generic Drugs, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Edoxaban Tosilate Tablets and Generic Drugs, also provides the sales of main regions and countries. Of the upcoming market potential for Edoxaban Tosilate Tablets and Generic Drugs, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Edoxaban Tosilate Tablets and Generic Drugs sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Edoxaban Tosilate Tablets and Generic Drugs market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Edoxaban Tosilate Tablets and Generic Drugs sales, projected growth trends, production technology, application and end-user industry.

Edoxaban Tosilate Tablets and Generic Drugs Segment by Company

Daiichi Sankyo

Lunan Pharmaceutical Group

Menarini Group

Simcere Pharmaceutical

Edoxaban Tosilate Tablets and Generic Drugs Segment by Type

30 mg

60 mg

Other

Edoxaban Tosilate Tablets and Generic Drugs Segment by Application

Hospital

Clinic

Other

Edoxaban Tosilate Tablets and Generic Drugs Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Edoxaban Tosilate Tablets and Generic Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Edoxaban Tosilate Tablets and Generic Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Edoxaban Tosilate Tablets and Generic Drugs.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Edoxaban Tosilate Tablets and Generic Drugs in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Edoxaban Tosilate Tablets and Generic Drugs manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Edoxaban Tosilate Tablets and Generic Drugs sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Edoxaban Tosilate Tablets and Generic Drugs Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. 30 mg Major Manufacturers Table 3. 60 mg Major Manufacturers Table 4. Other Major Manufacturers Table 5. Global Edoxaban Tosilate Tablets and Generic Drugs Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 6. Hospital Major Manufacturers Table 7. Clinic Major Manufacturers Table 8. Other Major Manufacturers Table 9. Edoxaban Tosilate Tablets and Generic Drugs Industry Trends Table 10. Edoxaban Tosilate Tablets and Generic Drugs Industry Drivers Table 11. Edoxaban Tosilate Tablets and Generic Drugs Industry Opportunities and Challenges Table 12. Edoxaban Tosilate Tablets and Generic Drugs Industry Restraints Table 13. Global Edoxaban Tosilate Tablets and Generic Drugs Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 14. Global Edoxaban Tosilate Tablets and Generic Drugs Revenue by Region (2021-2026) & (US$ Million) Table 15. Global Edoxaban Tosilate Tablets and Generic Drugs Revenue by Region (2027-2032) & (US$ Million) Table 16. Global Edoxaban Tosilate Tablets and Generic Drugs Revenue Market Share by Region (2021-2026) Table 17. Global Edoxaban Tosilate Tablets and Generic Drugs Revenue Market Share by Region (2027-2032) Table 18. Global Edoxaban Tosilate Tablets and Generic Drugs Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (K Units) Table 19. Global Edoxaban Tosilate Tablets and Generic Drugs Sales by Region (2021-2026) & (K Units) Table 20. Global Edoxaban Tosilate Tablets and Generic Drugs Sales by Region (2027-2032) & (K Units) Table 21. Global Edoxaban Tosilate Tablets and Generic Drugs Sales Market Share by Region (2021-2026) Table 22. Global Edoxaban Tosilate Tablets and Generic Drugs Sales Market Share by Region (2027-2032) Table 23. Global Edoxaban Tosilate Tablets and Generic Drugs Revenue by Manufacturers (US$ Million) & (2021-2026) Table 24. Global Edoxaban Tosilate Tablets and Generic Drugs Revenue Market Share by Manufacturers (2021-2026) Table 25. Global Edoxaban Tosilate Tablets and Generic Drugs Sales by Manufacturers (US$ Million) & (2021-2026) Table 26. Global Edoxaban Tosilate Tablets and Generic Drugs Sales Market Share by Manufacturers (2021-2026) Table 27. Global Edoxaban Tosilate Tablets and Generic Drugs Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 28. Global Edoxaban Tosilate Tablets and Generic Drugs Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 29. Global Edoxaban Tosilate Tablets and Generic Drugs Key Manufacturers Manufacturing Sites & Headquarters Table 30. Global Edoxaban Tosilate Tablets and Generic Drugs Manufacturers, Product Type & Application Table 31. Global Edoxaban Tosilate Tablets and Generic Drugs Manufacturers' Establishment Date Table 32. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 33. Global Edoxaban Tosilate Tablets and Generic Drugs by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 34. Global Edoxaban Tosilate Tablets and Generic Drugs Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 35. Global Edoxaban Tosilate Tablets and Generic Drugs Revenue by Type (2021-2026) & (US$ Million) Table 36. Global Edoxaban Tosilate Tablets and Generic Drugs Revenue by Type (2027-2032) & (US$ Million) Table 37. Global Edoxaban Tosilate Tablets and Generic Drugs Revenue Market Share by Type (2021-2026) Table 38. Global Edoxaban Tosilate Tablets and Generic Drugs Revenue Market Share by Type (2027-2032) Table 39. Global Edoxaban Tosilate Tablets and Generic Drugs Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 40. Global Edoxaban Tosilate Tablets and Generic Drugs Sales by Type (2021-2026) & (K Units) Table 41. Global Edoxaban Tosilate Tablets and Generic Drugs Sales by Type (2027-2032) & (K Units) Table 42. Global Edoxaban Tosilate Tablets and Generic Drugs Sales Market Share by Type (2021-2026) Table 43. Global Edoxaban Tosilate Tablets and Generic Drugs Sales Market Share by Type (2027-2032) Table 44. Global Edoxaban Tosilate Tablets and Generic Drugs Price by Type (2021-2026) & (US$/Unit) Table 45. Global Edoxaban Tosilate Tablets and Generic Drugs Price by Type (2027-2032) & (US$/Unit) Table 46. Global Edoxaban Tosilate Tablets and Generic Drugs Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 47. Global Edoxaban Tosilate Tablets and Generic Drugs Revenue by Application (2021-2026) & (US$ Million) Table 48. Global Edoxaban Tosilate Tablets and Generic Drugs Revenue by Application (2027-2032) & (US$ Million) Table 49. Global Edoxaban Tosilate Tablets and Generic Drugs Revenue Market Share by Application (2021-2026) Table 50. Global Edoxaban Tosilate Tablets and Generic Drugs Revenue Market Share by Application (2027-2032) Table 51. Global Edoxaban Tosilate Tablets and Generic Drugs Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 52. Global Edoxaban Tosilate Tablets and Generic Drugs Sales by Application (2021-2026) & (K Units) Table 53. Global Edoxaban Tosilate Tablets and Generic Drugs Sales by Application (2027-2032) & (K Units) Table 54. Global Edoxaban Tosilate Tablets and Generic Drugs Sales Market Share by Application (2021-2026) Table 55. Global Edoxaban Tosilate Tablets and Generic Drugs Sales Market Share by Application (2027-2032) Table 56. Global Edoxaban Tosilate Tablets and Generic Drugs Price by Application (2021-2026) & (US$/Unit) Table 57. Global Edoxaban Tosilate Tablets and Generic Drugs Price by Application (2027-2032) & (US$/Unit) Table 58. Daiichi Sankyo Company Information Table 59. Daiichi Sankyo Business Overview Table 60. Daiichi Sankyo Edoxaban Tosilate Tablets and Generic Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 61. Daiichi Sankyo Edoxaban Tosilate Tablets and Generic Drugs Product Portfolio Table 62. Daiichi Sankyo Recent Development Table 63. Lunan Pharmaceutical Group Company Information Table 64. Lunan Pharmaceutical Group Business Overview Table 65. Lunan Pharmaceutical Group Edoxaban Tosilate Tablets and Generic Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 66. Lunan Pharmaceutical Group Edoxaban Tosilate Tablets and Generic Drugs Product Portfolio Table 67. Lunan Pharmaceutical Group Recent Development Table 68. Menarini Group Company Information Table 69. Menarini Group Business Overview Table 70. Menarini Group Edoxaban Tosilate Tablets and Generic Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 71. Menarini Group Edoxaban Tosilate Tablets and Generic Drugs Product Portfolio Table 72. Menarini Group Recent Development Table 73. Simcere Pharmaceutical Company Information Table 74. Simcere Pharmaceutical Business Overview Table 75. Simcere Pharmaceutical Edoxaban Tosilate Tablets and Generic Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 76. Simcere Pharmaceutical Edoxaban Tosilate Tablets and Generic Drugs Product Portfolio Table 77. Simcere Pharmaceutical Recent Development Table 78. North America Edoxaban Tosilate Tablets and Generic Drugs Revenue by Type (2021-2026) & (US$ Million) Table 79. North America Edoxaban Tosilate Tablets and Generic Drugs Revenue by Type (2027-2032) & (US$ Million) Table 80. North America Edoxaban Tosilate Tablets and Generic Drugs Sales by Type (2021-2026) & (K Units) Table 81. North America Edoxaban Tosilate Tablets and Generic Drugs Sales by Type (2027-2032) & (K Units) Table 82. North America Edoxaban Tosilate Tablets and Generic Drugs Sales Price by Type (2021-2026) & (US$/Unit) Table 83. North America Edoxaban Tosilate Tablets and Generic Drugs Sales Price by Type (2027-2032) & (US$/Unit) Table 84. North America Edoxaban Tosilate Tablets and Generic Drugs Revenue by Application (2021-2026) & (US$ Million) Table 85. North America Edoxaban Tosilate Tablets and Generic Drugs Revenue by Application (2027-2032) & (US$ Million) Table 86. North America Edoxaban Tosilate Tablets and Generic Drugs Sales by Application (2021-2026) & (K Units) Table 87. North America Edoxaban Tosilate Tablets and Generic Drugs Sales by Application (2027-2032) & (K Units) Table 88. North America Edoxaban Tosilate Tablets and Generic Drugs Sales Price by Application (2021-2026) & (US$/Unit) Table 89. North America Edoxaban Tosilate Tablets and Generic Drugs Sales Price by Application (2027-2032) & (US$/Unit) Table 90. North America Edoxaban Tosilate Tablets and Generic Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 91. North America Edoxaban Tosilate Tablets and Generic Drugs Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 92. North America Edoxaban Tosilate Tablets and Generic Drugs Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 93. North America Edoxaban Tosilate Tablets and Generic Drugs Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 94. North America Edoxaban Tosilate Tablets and Generic Drugs Sales by Country (2021-2026) & (K Units) Table 95. North America Edoxaban Tosilate Tablets and Generic Drugs Sales by Country (2027-2032) & (K Units) Table 96. North America Edoxaban Tosilate Tablets and Generic Drugs Sales Price by Country (2021-2026) & (US$/Unit) Table 97. North America Edoxaban Tosilate Tablets and Generic Drugs Sales Price by Country (2027-2032) & (US$/Unit) Table 98. United States Edoxaban Tosilate Tablets and Generic Drugs Revenue (2021-2032) & (US$ Million) Table 99. Canada Edoxaban Tosilate Tablets and Generic Drugs Revenue (2021-2032) & (US$ Million) Table 100. Mexico Edoxaban Tosilate Tablets and Generic Drugs Revenue (2021-2032) & (US$ Million) Table 101. Europe Edoxaban Tosilate Tablets and Generic Drugs Revenue by Type (2021-2026) & (US$ Million) Table 102. Europe Edoxaban Tosilate Tablets and Generic Drugs Revenue by Type (2027-2032) & (US$ Million) Table 103. Europe Edoxaban Tosilate Tablets and Generic Drugs Sales by Type (2021-2026) & (K Units) Table 104. Europe Edoxaban Tosilate Tablets and Generic Drugs Sales by Type (2027-2032) & (K Units) Table 105. Europe Edoxaban Tosilate Tablets and Generic Drugs Sales Price by Type (2021-2026) & (US$/Unit) Table 106. Europe Edoxaban Tosilate Tablets and Generic Drugs Sales Price by Type (2027-2032) & (US$/Unit) Table 107. Europe Edoxaban Tosilate Tablets and Generic Drugs Revenue by Application (2021-2026) & (US$ Million) Table 108. Europe Edoxaban Tosilate Tablets and Generic Drugs Revenue by Application (2027-2032) & (US$ Million) Table 109. Europe Edoxaban Tosilate Tablets and Generic Drugs Sales by Application (2021-2026) & (K Units) Table 110. Europe Edoxaban Tosilate Tablets and Generic Drugs Sales by Application (2027-2032) & (K Units) Table 111. Europe Edoxaban Tosilate Tablets and Generic Drugs Sales Price by Application (2021-2026) & (US$/Unit) Table 112. Europe Edoxaban Tosilate Tablets and Generic Drugs Sales Price by Application (2027-2032) & (US$/Unit) Table 113. Europe Edoxaban Tosilate Tablets and Generic Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 114. Europe Edoxaban Tosilate Tablets and Generic Drugs Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 115. Europe Edoxaban Tosilate Tablets and Generic Drugs Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 116. Europe Edoxaban Tosilate Tablets and Generic Drugs Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 117. Europe Edoxaban Tosilate Tablets and Generic Drugs Sales by Country (2021-2026) & (K Units) Table 118. Europe Edoxaban Tosilate Tablets and Generic Drugs Sales by Country (2027-2032) & (K Units) Table 119. Europe Edoxaban Tosilate Tablets and Generic Drugs Sales Price by Country (2021-2026) & (US$/Unit) Table 120. Europe Edoxaban Tosilate Tablets and Generic Drugs Sales Price by Country (2027-2032) & (US$/Unit) Table 121. Germany Edoxaban Tosilate Tablets and Generic Drugs Revenue (2021-2032) & (US$ Million) Table 122. France Edoxaban Tosilate Tablets and Generic Drugs Revenue (2021-2032) & (US$ Million) Table 123. U.K. Edoxaban Tosilate Tablets and Generic Drugs Revenue (2021-2032) & (US$ Million) Table 124. Italy Edoxaban Tosilate Tablets and Generic Drugs Revenue (2021-2032) & (US$ Million) Table 125. Russia Edoxaban Tosilate Tablets and Generic Drugs Revenue (2021-2032) & (US$ Million) Table 126. Spain Edoxaban Tosilate Tablets and Generic Drugs Revenue (2021-2032) & (US$ Million) Table 127. Netherlands Edoxaban Tosilate Tablets and Generic Drugs Revenue (2021-2032) & (US$ Million) Table 128. Switzerland Edoxaban Tosilate Tablets and Generic Drugs Revenue (2021-2032) & (US$ Million) Table 129. Sweden Edoxaban Tosilate Tablets and Generic Drugs Revenue (2021-2032) & (US$ Million) Table 130. Poland Edoxaban Tosilate Tablets and Generic Drugs Revenue (2021-2032) & (US$ Million) Table 131. China Edoxaban Tosilate Tablets and Generic Drugs Revenue by Type (2021-2026) & (US$ Million) Table 132. China Edoxaban Tosilate Tablets and Generic Drugs Revenue by Type (2027-2032) & (US$ Million) Table 133. China Edoxaban Tosilate Tablets and Generic Drugs Sales by Type (2021-2026) & (K Units) Table 134. China Edoxaban Tosilate Tablets and Generic Drugs Sales by Type (2027-2032) & (K Units) Table 135. China Edoxaban Tosilate Tablets and Generic Drugs Sales Price by Type (2021-2026) & (US$/Unit) Table 136. China Edoxaban Tosilate Tablets and Generic Drugs Sales Price by Type (2027-2032) & (US$/Unit) Table 137. China Edoxaban Tosilate Tablets and Generic Drugs Revenue by Application (2021-2026) & (US$ Million) Table 138. China Edoxaban Tosilate Tablets and Generic Drugs Revenue by Application (2027-2032) & (US$ Million) Table 139. China Edoxaban Tosilate Tablets and Generic Drugs Sales by Application (2021-2026) & (K Units) Table 140. China Edoxaban Tosilate Tablets and Generic Drugs Sales by Application (2027-2032) & (K Units) Table 141. China Edoxaban Tosilate Tablets and Generic Drugs Sales Price by Application (2021-2026) & (US$/Unit) Table 142. China Edoxaban Tosilate Tablets and Generic Drugs Sales Price by Application (2027-2032) & (US$/Unit) Table 143. Asia Edoxaban Tosilate Tablets and Generic Drugs Revenue by Type (2021-2026) & (US$ Million) Table 144. Asia Edoxaban Tosilate Tablets and Generic Drugs Revenue by Type (2027-2032) & (US$ Million) Table 145. Asia Edoxaban Tosilate Tablets and Generic Drugs Sales by Type (2021-2026) & (K Units) Table 146. Asia Edoxaban Tosilate Tablets and Generic Drugs Sales by Type (2027-2032) & (K Units) Table 147. Asia Edoxaban Tosilate Tablets and Generic Drugs Sales Price by Type (2021-2026) & (US$/Unit) Table 148. Asia Edoxaban Tosilate Tablets and Generic Drugs Sales Price by Type (2027-2032) & (US$/Unit) Table 149. Asia Edoxaban Tosilate Tablets and Generic Drugs Revenue by Application (2021-2026) & (US$ Million) Table 150. Asia Edoxaban Tosilate Tablets and Generic Drugs Revenue by Application (2027-2032) & (US$ Million) Table 151. Asia Edoxaban Tosilate Tablets and Generic Drugs Sales by Application (2021-2026) & (K Units) Table 152. Asia Edoxaban Tosilate Tablets and Generic Drugs Sales by Application (2027-2032) & (K Units) Table 153. Asia Edoxaban Tosilate Tablets and Generic Drugs Sales Price by Application (2021-2026) & (US$/Unit) Table 154. Asia Edoxaban Tosilate Tablets and Generic Drugs Sales Price by Application (2027-2032) & (US$/Unit) Table 155. Asia Edoxaban Tosilate Tablets and Generic Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 156. Asia Edoxaban Tosilate Tablets and Generic Drugs Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 157. Asia Edoxaban Tosilate Tablets and Generic Drugs Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 158. Asia Edoxaban Tosilate Tablets and Generic Drugs Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 159. Asia Edoxaban Tosilate Tablets and Generic Drugs Sales by Country (2021-2026) & (K Units) Table 160. Asia Edoxaban Tosilate Tablets and Generic Drugs Sales by Country (2027-2032) & (K Units) Table 161. Asia Edoxaban Tosilate Tablets and Generic Drugs Sales Price by Country (2021-2026) & (US$/Unit) Table 162. Asia Edoxaban Tosilate Tablets and Generic Drugs Sales Price by Country (2027-2032) & (US$/Unit) Table 163. Japan Edoxaban Tosilate Tablets and Generic Drugs Revenue (2021-2032) & (US$ Million) Table 164. South Korea Edoxaban Tosilate Tablets and Generic Drugs Revenue (2021-2032) & (US$ Million) Table 165. India Edoxaban Tosilate Tablets and Generic Drugs Revenue (2021-2032) & (US$ Million) Table 166. Australia Edoxaban Tosilate Tablets and Generic Drugs Revenue (2021-2032) & (US$ Million) Table 167. Taiwan Edoxaban Tosilate Tablets and Generic Drugs Revenue (2021-2032) & (US$ Million) Table 168. Southeast Asia Edoxaban Tosilate Tablets and Generic Drugs Revenue (2021-2032) & (US$ Million) Table 169. SAMEA Edoxaban Tosilate Tablets and Generic Drugs Revenue by Type (2021-2026) & (US$ Million) Table 170. SAMEA Edoxaban Tosilate Tablets and Generic Drugs Revenue by Type (2027-2032) & (US$ Million) Table 171. SAMEA Edoxaban Tosilate Tablets and Generic Drugs Sales by Type (2021-2026) & (K Units) Table 172. SAMEA Edoxaban Tosilate Tablets and Generic Drugs Sales by Type (2027-2032) & (K Units) Table 173. SAMEA Edoxaban Tosilate Tablets and Generic Drugs Sales Price by Type (2021-2026) & (US$/Unit) Table 174. SAMEA Edoxaban Tosilate Tablets and Generic Drugs Sales Price by Type (2027-2032) & (US$/Unit) Table 175. SAMEA Edoxaban Tosilate Tablets and Generic Drugs Revenue by Application (2021-2026) & (US$ Million) Table 176. SAMEA Edoxaban Tosilate Tablets and Generic Drugs Revenue by Application (2027-2032) & (US$ Million) Table 177. SAMEA Edoxaban Tosilate Tablets and Generic Drugs Sales by Application (2021-2026) & (K Units) Table 178. SAMEA Edoxaban Tosilate Tablets and Generic Drugs Sales by Application (2027-2032) & (K Units) Table 179. SAMEA Edoxaban Tosilate Tablets and Generic Drugs Sales Price by Application (2021-2026) & (US$/Unit) Table 180. SAMEA Edoxaban Tosilate Tablets and Generic Drugs Sales Price by Application (2027-2032) & (US$/Unit) Table 181. SAMEA Edoxaban Tosilate Tablets and Generic Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 182. SAMEA Edoxaban Tosilate Tablets and Generic Drugs Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 183. SAMEA Edoxaban Tosilate Tablets and Generic Drugs Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 184. SAMEA Edoxaban Tosilate Tablets and Generic Drugs Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 185. SAMEA Edoxaban Tosilate Tablets and Generic Drugs Sales by Country (2021-2026) & (K Units) Table 186. SAMEA Edoxaban Tosilate Tablets and Generic Drugs Sales by Country (2027-2032) & (K Units) Table 187. SAMEA Edoxaban Tosilate Tablets and Generic Drugs Sales Price by Country (2021-2026) & (US$/Unit) Table 188. SAMEA Edoxaban Tosilate Tablets and Generic Drugs Sales Price by Country (2027-2032) & (US$/Unit) Table 189. Brazil Edoxaban Tosilate Tablets and Generic Drugs Revenue (2021-2032) & (US$ Million) Table 190. Argentina Edoxaban Tosilate Tablets and Generic Drugs Revenue (2021-2032) & (US$ Million) Table 191. Chile Edoxaban Tosilate Tablets and Generic Drugs Revenue (2021-2032) & (US$ Million) Table 192. Colombia Edoxaban Tosilate Tablets and Generic Drugs Revenue (2021-2032) & (US$ Million) Table 193. Peru Edoxaban Tosilate Tablets and Generic Drugs Revenue (2021-2032) & (US$ Million) Table 194. Saudi Arabia Edoxaban Tosilate Tablets and Generic Drugs Revenue (2021-2032) & (US$ Million) Table 195. Israel Edoxaban Tosilate Tablets and Generic Drugs Revenue (2021-2032) & (US$ Million) Table 196. UAE Edoxaban Tosilate Tablets and Generic Drugs Revenue (2021-2032) & (US$ Million) Table 197. Turkey Edoxaban Tosilate Tablets and Generic Drugs Revenue (2021-2032) & (US$ Million) Table 198. Iran Edoxaban Tosilate Tablets and Generic Drugs Revenue (2021-2032) & (US$ Million) Table 199. Egypt Edoxaban Tosilate Tablets and Generic Drugs Revenue (2021-2032) & (US$ Million) Table 200. Key Raw Materials Table 201. Raw Materials Key Suppliers Table 202. Edoxaban Tosilate Tablets and Generic Drugs Distributors List Table 203. Edoxaban Tosilate Tablets and Generic Drugs Customers List Table 204. Research Programs/Design for This Report Table 205. Authors List of This Report Table 206. Secondary Sources Table 207. Primary Sources List of Figures Figure 1. Edoxaban Tosilate Tablets and Generic Drugs Image Figure 2. Global Edoxaban Tosilate Tablets and Generic Drugs Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Edoxaban Tosilate Tablets and Generic Drugs Market Size Share 2021 VS 2025 VS 2032 Figure 4. 30 mg Image Figure 5. 60 mg Image Figure 6. Other Image Figure 7. Global Edoxaban Tosilate Tablets and Generic Drugs Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 8. Global Edoxaban Tosilate Tablets and Generic Drugs Market Size Share 2021 VS 2025 VS 2032 Figure 9. Hospital Image Figure 10. Clinic Image Figure 11. Other Image Figure 12. Global Edoxaban Tosilate Tablets and Generic Drugs Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 13. Global Edoxaban Tosilate Tablets and Generic Drugs Revenue (2021-2032) & (US$ Million) Figure 14. Global Edoxaban Tosilate Tablets and Generic Drugs Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 15. Global Edoxaban Tosilate Tablets and Generic Drugs Revenue Market Share by Region: 2025 Versus 2032 Figure 16. Global Edoxaban Tosilate Tablets and Generic Drugs Revenue Market Share by Region (2021-2032) Figure 17. Global Edoxaban Tosilate Tablets and Generic Drugs Sales (2021-2032) & (K Units) Figure 18. Global Edoxaban Tosilate Tablets and Generic Drugs Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 19. Global Edoxaban Tosilate Tablets and Generic Drugs Sales Market Share by Region (2021-2032) Figure 20. US & Canada & Mexico Edoxaban Tosilate Tablets and Generic Drugs Sales YoY (2021-2032) & (K Units) Figure 21. Europe Edoxaban Tosilate Tablets and Generic Drugs Sales YoY (2021-2032) & (K Units) Figure 22. China Edoxaban Tosilate Tablets and Generic Drugs Sales YoY (2021-2032) & (K Units) Figure 23. Asia (Excluding China) Edoxaban Tosilate Tablets and Generic Drugs Sales YoY (2021-2032) & (K Units) Figure 24. South America, Middle East and Africa Edoxaban Tosilate Tablets and Generic Drugs Sales YoY (2021-2032) & (K Units) Figure 25. Global Edoxaban Tosilate Tablets and Generic Drugs Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 26. Global Edoxaban Tosilate Tablets and Generic Drugs Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 27. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 28. Global Edoxaban Tosilate Tablets and Generic Drugs Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 29. Global Edoxaban Tosilate Tablets and Generic Drugs Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 30. Global Edoxaban Tosilate Tablets and Generic Drugs Revenue Market Share by Type (2021-2032) Figure 31. Global Edoxaban Tosilate Tablets and Generic Drugs Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 32. Global Edoxaban Tosilate Tablets and Generic Drugs Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 33. Global Edoxaban Tosilate Tablets and Generic Drugs Sales Market Share by Type (2021-2032) Figure 34. Global Edoxaban Tosilate Tablets and Generic Drugs Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 35. Global Edoxaban Tosilate Tablets and Generic Drugs Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 36. Global Edoxaban Tosilate Tablets and Generic Drugs Revenue Market Share by Application (2021-2032) Figure 37. Global Edoxaban Tosilate Tablets and Generic Drugs Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 38. Global Edoxaban Tosilate Tablets and Generic Drugs Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 39. Global Edoxaban Tosilate Tablets and Generic Drugs Sales Market Share by Application (2021-2032) Figure 40. North America Edoxaban Tosilate Tablets and Generic Drugs Revenue Share by Type (2021-2032) Figure 41. North America Edoxaban Tosilate Tablets and Generic Drugs Sales Share by Type (2021-2032) Figure 42. North America Edoxaban Tosilate Tablets and Generic Drugs Revenue Share by Application (2021-2032) Figure 43. North America Edoxaban Tosilate Tablets and Generic Drugs Sales Share by Application (2021-2032) Figure 44. North America Edoxaban Tosilate Tablets and Generic Drugs Revenue Share by Country (2021-2032) Figure 45. North America Edoxaban Tosilate Tablets and Generic Drugs Sales Share by Country (2021-2032) Figure 46. Europe Edoxaban Tosilate Tablets and Generic Drugs Revenue Share by Type (2021-2032) Figure 47. Europe Edoxaban Tosilate Tablets and Generic Drugs Sales Share by Type (2021-2032) Figure 48. Europe Edoxaban Tosilate Tablets and Generic Drugs Revenue Share by Application (2021-2032) Figure 49. Europe Edoxaban Tosilate Tablets and Generic Drugs Sales Share by Application (2021-2032) Figure 50. Europe Edoxaban Tosilate Tablets and Generic Drugs Revenue Share by Country (2021-2032) Figure 51. Europe Edoxaban Tosilate Tablets and Generic Drugs Sales Share by Country (2021-2032) Figure 52. China Edoxaban Tosilate Tablets and Generic Drugs Revenue Share by Type (2021-2032) Figure 53. China Edoxaban Tosilate Tablets and Generic Drugs Sales Share by Type (2021-2032) Figure 54. China Edoxaban Tosilate Tablets and Generic Drugs Revenue Share by Application (2021-2032) Figure 55. China Edoxaban Tosilate Tablets and Generic Drugs Sales Share by Application (2021-2032) Figure 56. Asia Edoxaban Tosilate Tablets and Generic Drugs Revenue Share by Type (2021-2032) Figure 57. Asia Edoxaban Tosilate Tablets and Generic Drugs Sales Share by Type (2021-2032) Figure 58. Asia Edoxaban Tosilate Tablets and Generic Drugs Revenue Share by Application (2021-2032) Figure 59. Asia Edoxaban Tosilate Tablets and Generic Drugs Sales Share by Application (2021-2032) Figure 60. Asia Edoxaban Tosilate Tablets and Generic Drugs Revenue Share by Country (2021-2032) Figure 61. Asia Edoxaban Tosilate Tablets and Generic Drugs Sales Share by Country (2021-2032) Figure 62. SAMEA Edoxaban Tosilate Tablets and Generic Drugs Revenue Share by Type (2021-2032) Figure 63. SAMEA Edoxaban Tosilate Tablets and Generic Drugs Sales Share by Type (2021-2032) Figure 64. SAMEA Edoxaban Tosilate Tablets and Generic Drugs Revenue Share by Application (2021-2032) Figure 65. SAMEA Edoxaban Tosilate Tablets and Generic Drugs Sales Share by Application (2021-2032) Figure 66. SAMEA Edoxaban Tosilate Tablets and Generic Drugs Revenue Share by Country (2021-2032) Figure 67. SAMEA Edoxaban Tosilate Tablets and Generic Drugs Sales Share by Country (2021-2032) Figure 68. Edoxaban Tosilate Tablets and Generic Drugs Value Chain Figure 69. Manufacturing Cost Structure Figure 70. Edoxaban Tosilate Tablets and Generic Drugs Production Mode & Process Figure 71. Direct Comparison with Distribution Share Figure 72. Distributors Profiles Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • 30 mg
  • 60 mg
  • Other
Applications
  • Hospital
  • Clinic
  • Other
Companies covered
  • Daiichi Sankyo
  • Lunan Pharmaceutical Group
  • Menarini Group
  • Simcere Pharmaceutical

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Edoxaban Tosilate Tablets and Generic Drugs Market by Type
  3. 1.2.1 Global Edoxaban Tosilate Tablets and Generic Drugs Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 30 mg
  5. 1.2.3 60 mg
  6. 1.2.4 Other
  7. 1.3 Edoxaban Tosilate Tablets and Generic Drugs Market by Application
  8. 1.3.1 Global Edoxaban Tosilate Tablets and Generic Drugs Market Size by Application, 2021 VS 2025 VS 2032
  9. 1.3.2 Hospital
  10. 1.3.3 Clinic
  11. 1.3.4 Other
  12. 1.4 Assumptions and Limitations
  13. 1.5 Study Goals and Objectives
2 Edoxaban Tosilate Tablets and Generic Drugs Market Dynamics
  1. 2.1 Edoxaban Tosilate Tablets and Generic Drugs Industry Trends
  2. 2.2 Edoxaban Tosilate Tablets and Generic Drugs Industry Drivers
  3. 2.3 Edoxaban Tosilate Tablets and Generic Drugs Industry Opportunities and Challenges
  4. 2.4 Edoxaban Tosilate Tablets and Generic Drugs Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Edoxaban Tosilate Tablets and Generic Drugs Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Edoxaban Tosilate Tablets and Generic Drugs Revenue by Region
  3. 3.2.1 Global Edoxaban Tosilate Tablets and Generic Drugs Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Edoxaban Tosilate Tablets and Generic Drugs Revenue by Region (2021-2026)
  5. 3.2.3 Global Edoxaban Tosilate Tablets and Generic Drugs Revenue by Region (2027-2032)
  6. 3.2.4 Global Edoxaban Tosilate Tablets and Generic Drugs Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Edoxaban Tosilate Tablets and Generic Drugs Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Edoxaban Tosilate Tablets and Generic Drugs Sales by Region
  9. 3.4.1 Global Edoxaban Tosilate Tablets and Generic Drugs Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Edoxaban Tosilate Tablets and Generic Drugs Sales by Region (2021-2026)
  11. 3.4.3 Global Edoxaban Tosilate Tablets and Generic Drugs Sales by Region (2027-2032)
  12. 3.4.4 Global Edoxaban Tosilate Tablets and Generic Drugs Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Edoxaban Tosilate Tablets and Generic Drugs Revenue by Manufacturers
  2. 4.1.1 Global Edoxaban Tosilate Tablets and Generic Drugs Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Edoxaban Tosilate Tablets and Generic Drugs Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Edoxaban Tosilate Tablets and Generic Drugs Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Edoxaban Tosilate Tablets and Generic Drugs Sales by Manufacturers
  6. 4.2.1 Global Edoxaban Tosilate Tablets and Generic Drugs Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Edoxaban Tosilate Tablets and Generic Drugs Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Edoxaban Tosilate Tablets and Generic Drugs Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Edoxaban Tosilate Tablets and Generic Drugs Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Edoxaban Tosilate Tablets and Generic Drugs Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Edoxaban Tosilate Tablets and Generic Drugs Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Edoxaban Tosilate Tablets and Generic Drugs Manufacturers, Product Type & Application
  13. 4.7 Global Edoxaban Tosilate Tablets and Generic Drugs Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Edoxaban Tosilate Tablets and Generic Drugs Market CR5 and HHI
  16. 4.8.2 2025 Edoxaban Tosilate Tablets and Generic Drugs Tier 1, Tier 2, and Tier 3
5 Edoxaban Tosilate Tablets and Generic Drugs Market by Type
  1. 5.1 Global Edoxaban Tosilate Tablets and Generic Drugs Revenue by Type
  2. 5.1.1 Global Edoxaban Tosilate Tablets and Generic Drugs Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Edoxaban Tosilate Tablets and Generic Drugs Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Edoxaban Tosilate Tablets and Generic Drugs Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Edoxaban Tosilate Tablets and Generic Drugs Sales by Type
  6. 5.2.1 Global Edoxaban Tosilate Tablets and Generic Drugs Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Edoxaban Tosilate Tablets and Generic Drugs Sales by Type (2021-2032) & (K Units)
  8. 5.2.3 Global Edoxaban Tosilate Tablets and Generic Drugs Sales Market Share by Type (2021-2032)
  9. 5.3 Global Edoxaban Tosilate Tablets and Generic Drugs Price by Type
6 Edoxaban Tosilate Tablets and Generic Drugs Market by Application
  1. 6.1 Global Edoxaban Tosilate Tablets and Generic Drugs Revenue by Application
  2. 6.1.1 Global Edoxaban Tosilate Tablets and Generic Drugs Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Edoxaban Tosilate Tablets and Generic Drugs Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Edoxaban Tosilate Tablets and Generic Drugs Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Edoxaban Tosilate Tablets and Generic Drugs Sales by Application
  6. 6.2.1 Global Edoxaban Tosilate Tablets and Generic Drugs Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Edoxaban Tosilate Tablets and Generic Drugs Sales by Application (2021-2032) & (K Units)
  8. 6.2.3 Global Edoxaban Tosilate Tablets and Generic Drugs Sales Market Share by Application (2021-2032)
  9. 6.3 Global Edoxaban Tosilate Tablets and Generic Drugs Price by Application
7 Company Profiles
  1. 7.1 Daiichi Sankyo
  2. 7.1.1 Daiichi Sankyo Company Information
  3. 7.1.2 Daiichi Sankyo Business Overview
  4. 7.1.3 Daiichi Sankyo Edoxaban Tosilate Tablets and Generic Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Daiichi Sankyo Edoxaban Tosilate Tablets and Generic Drugs Product Portfolio
  6. 7.1.5 Daiichi Sankyo Recent Developments
  7. 7.2 Lunan Pharmaceutical Group
  8. 7.2.1 Lunan Pharmaceutical Group Company Information
  9. 7.2.2 Lunan Pharmaceutical Group Business Overview
  10. 7.2.3 Lunan Pharmaceutical Group Edoxaban Tosilate Tablets and Generic Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Lunan Pharmaceutical Group Edoxaban Tosilate Tablets and Generic Drugs Product Portfolio
  12. 7.2.5 Lunan Pharmaceutical Group Recent Developments
  13. 7.3 Menarini Group
  14. 7.3.1 Menarini Group Company Information
  15. 7.3.2 Menarini Group Business Overview
  16. 7.3.3 Menarini Group Edoxaban Tosilate Tablets and Generic Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Menarini Group Edoxaban Tosilate Tablets and Generic Drugs Product Portfolio
  18. 7.3.5 Menarini Group Recent Developments
  19. 7.4 Simcere Pharmaceutical
  20. 7.4.1 Simcere Pharmaceutical Company Information
  21. 7.4.2 Simcere Pharmaceutical Business Overview
  22. 7.4.3 Simcere Pharmaceutical Edoxaban Tosilate Tablets and Generic Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Simcere Pharmaceutical Edoxaban Tosilate Tablets and Generic Drugs Product Portfolio
  24. 7.4.5 Simcere Pharmaceutical Recent Developments
8 North America
  1. 8.1 North America Edoxaban Tosilate Tablets and Generic Drugs Market Size by Type
  2. 8.1.1 North America Edoxaban Tosilate Tablets and Generic Drugs Revenue by Type (2021-2032)
  3. 8.1.2 North America Edoxaban Tosilate Tablets and Generic Drugs Sales by Type (2021-2032)
  4. 8.1.3 North America Edoxaban Tosilate Tablets and Generic Drugs Price by Type (2021-2032)
  5. 8.2 North America Edoxaban Tosilate Tablets and Generic Drugs Market Size by Application
  6. 8.2.1 North America Edoxaban Tosilate Tablets and Generic Drugs Revenue by Application (2021-2032)
  7. 8.2.2 North America Edoxaban Tosilate Tablets and Generic Drugs Sales by Application (2021-2032)
  8. 8.2.3 North America Edoxaban Tosilate Tablets and Generic Drugs Price by Application (2021-2032)
  9. 8.3 North America Edoxaban Tosilate Tablets and Generic Drugs Market Size by Country
  10. 8.3.1 North America Edoxaban Tosilate Tablets and Generic Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Edoxaban Tosilate Tablets and Generic Drugs Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Edoxaban Tosilate Tablets and Generic Drugs Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Edoxaban Tosilate Tablets and Generic Drugs Market Size by Type
  2. 9.1.1 Europe Edoxaban Tosilate Tablets and Generic Drugs Revenue by Type (2021-2032)
  3. 9.1.2 Europe Edoxaban Tosilate Tablets and Generic Drugs Sales by Type (2021-2032)
  4. 9.1.3 Europe Edoxaban Tosilate Tablets and Generic Drugs Price by Type (2021-2032)
  5. 9.2 Europe Edoxaban Tosilate Tablets and Generic Drugs Market Size by Application
  6. 9.2.1 Europe Edoxaban Tosilate Tablets and Generic Drugs Revenue by Application (2021-2032)
  7. 9.2.2 Europe Edoxaban Tosilate Tablets and Generic Drugs Sales by Application (2021-2032)
  8. 9.2.3 Europe Edoxaban Tosilate Tablets and Generic Drugs Price by Application (2021-2032)
  9. 9.3 Europe Edoxaban Tosilate Tablets and Generic Drugs Market Size by Country
  10. 9.3.1 Europe Edoxaban Tosilate Tablets and Generic Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Edoxaban Tosilate Tablets and Generic Drugs Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Edoxaban Tosilate Tablets and Generic Drugs Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Edoxaban Tosilate Tablets and Generic Drugs Market Size by Type
  2. 10.1.1 China Edoxaban Tosilate Tablets and Generic Drugs Revenue by Type (2021-2032)
  3. 10.1.2 China Edoxaban Tosilate Tablets and Generic Drugs Sales by Type (2021-2032)
  4. 10.1.3 China Edoxaban Tosilate Tablets and Generic Drugs Price by Type (2021-2032)
  5. 10.2 China Edoxaban Tosilate Tablets and Generic Drugs Market Size by Application
  6. 10.2.1 China Edoxaban Tosilate Tablets and Generic Drugs Revenue by Application (2021-2032)
  7. 10.2.2 China Edoxaban Tosilate Tablets and Generic Drugs Sales by Application (2021-2032)
  8. 10.2.3 China Edoxaban Tosilate Tablets and Generic Drugs Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Edoxaban Tosilate Tablets and Generic Drugs Market Size by Type
  2. 11.1.1 Asia Edoxaban Tosilate Tablets and Generic Drugs Revenue by Type (2021-2032)
  3. 11.1.2 Asia Edoxaban Tosilate Tablets and Generic Drugs Sales by Type (2021-2032)
  4. 11.1.3 Asia Edoxaban Tosilate Tablets and Generic Drugs Price by Type (2021-2032)
  5. 11.2 Asia Edoxaban Tosilate Tablets and Generic Drugs Market Size by Application
  6. 11.2.1 Asia Edoxaban Tosilate Tablets and Generic Drugs Revenue by Application (2021-2032)
  7. 11.2.2 Asia Edoxaban Tosilate Tablets and Generic Drugs Sales by Application (2021-2032)
  8. 11.2.3 Asia Edoxaban Tosilate Tablets and Generic Drugs Price by Application (2021-2032)
  9. 11.3 Asia Edoxaban Tosilate Tablets and Generic Drugs Market Size by Country
  10. 11.3.1 Asia Edoxaban Tosilate Tablets and Generic Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Edoxaban Tosilate Tablets and Generic Drugs Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Edoxaban Tosilate Tablets and Generic Drugs Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Edoxaban Tosilate Tablets and Generic Drugs Market Size by Type
  2. 12.1.1 SAMEA Edoxaban Tosilate Tablets and Generic Drugs Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Edoxaban Tosilate Tablets and Generic Drugs Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Edoxaban Tosilate Tablets and Generic Drugs Price by Type (2021-2032)
  5. 12.2 SAMEA Edoxaban Tosilate Tablets and Generic Drugs Market Size by Application
  6. 12.2.1 SAMEA Edoxaban Tosilate Tablets and Generic Drugs Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Edoxaban Tosilate Tablets and Generic Drugs Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Edoxaban Tosilate Tablets and Generic Drugs Price by Application (2021-2032)
  9. 12.3 SAMEA Edoxaban Tosilate Tablets and Generic Drugs Market Size by Country
  10. 12.3.1 SAMEA Edoxaban Tosilate Tablets and Generic Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Edoxaban Tosilate Tablets and Generic Drugs Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Edoxaban Tosilate Tablets and Generic Drugs Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Edoxaban Tosilate Tablets and Generic Drugs Value Chain Analysis
  2. 13.1.1 Edoxaban Tosilate Tablets and Generic Drugs Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Edoxaban Tosilate Tablets and Generic Drugs Production Mode & Process
  6. 13.2 Edoxaban Tosilate Tablets and Generic Drugs Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Edoxaban Tosilate Tablets and Generic Drugs Distributors
  9. 13.2.3 Edoxaban Tosilate Tablets and Generic Drugs Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst